Product Feature: Nanosilver Wound Dressings

Nucryst Pharmaceuticals has developed medical coatings based on a proprietary method of applying a thin film of noble metal nanocrystals to base materials. This proprietary technique of depositing biocompatible metal to base materials produces sustained release of metal ions sufficient to produce an antimicrobial effect.

The Company's antimicrobial barrier dressings, the first commercial product of this technology, use silver as an antimicrobial coating. Their silver nanocrystals are considerably smaller, ranging between 1 and 100 nanometers, than conventional silver crystals. The size and structure of these crystals result in enhanced solubility and sustained release allowing wound dressings to maintain a fast-acting release of silver ions for up to 7 days.

The benefit to patients is that they require fewer, and less painful, dressing changes. Pain associated with serious wounds, such as those of burn victims, can be significant. Nucryst wound dressings last approxiamately a week and peel away without damaging the underlying wound bed. Burn centers across the globe are rapidly adopting the treatment.

Source: Company Website

Indexed By Tags: future, nanotech, nanotechnology, technology burn